In total, a 6-MRG- (AOC2, ENPP2, ADA, GPD1L, ACADL, and CPT2) based prognostic model was constructed based on the CRC patient clinical characteristics and expression quantity of MRGs. This evidence concerns the gene ADA and colorectal carcinoma.